Invention Grant
US07884197B2 Synthetic agonists of TLR9 失效
TLR9的合成激动剂

Synthetic agonists of TLR9
Abstract:
The invention provides novel oligonucleotide-based compounds that individually provide distinct immune response profiles through their interactions as agonists with TLR9. The TLR9 agonists according to the invention are characterized by specific and unique chemical modifications, which provide their distinctive immune response activation profiles.
Public/Granted literature
Information query
Patent Agency Ranking
0/0